We found that MARCH6 is upregulated in primary papillary thyroid cancers (PTCs), and this upregulation contributes to the promotion of thyroid cancer cell proliferation, migration and cell cycle progression. Here, MARCHF6 is linked to thyroid gland papillary carcinoma.